In this article, we will discuss Olaparib (Usage-2). So, let’s get started.
Advanced gBRCA-mutated Ovarian Cancer After 3 or More Lines of Chemotherapy
Olaparib is indicated for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy. Select patients for therapy based on an FDA-approved companion diagnostic for Olaparib.